Researchers from The Wistar Institute and ChristianaCare Identify Promising New Therapeutic Target for Pancreatic Cancer
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential therapy.
admin